Quarterly report · Q1
4571.TEDINET S100RNIY
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 21
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥59m | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥202m | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | −¥304m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥285m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥285m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥286m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥286m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥5.7bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2023-03-31 | Cons. | Assets |
| Total liabilities | ¥1.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥4.3bn | at 2023-03-31 | Cons. | Net assets |
| Cash and deposits | ¥2.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-4.07 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.7 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 222
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | Original text (Japanese)１単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)NANO MRNA株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中央区京橋一丁目４番10号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration | Original text (Japanese)当社グループは、医薬品等の研究開発及び製造販売並びにこれらの付随業務の単一セグメントであるため、記載は省略しております。 | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |